{"id":1787,"date":"2024-04-25T10:04:27","date_gmt":"2024-04-25T08:04:27","guid":{"rendered":"https:\/\/www.access2meds.eu\/?p=1787"},"modified":"2024-06-05T10:52:13","modified_gmt":"2024-06-05T08:52:13","slug":"presentation-of-aims-fair-price-model-to-the-belgian-parliament","status":"publish","type":"post","link":"https:\/\/www.access2meds.eu\/hr\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/","title":{"rendered":"Presentation of AIM’s Fair Price Model to the Belgian Parliament"},"content":{"rendered":"\n

Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris\u2019s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.<\/p>\n\n\n\n

Solidaris very successfully presented its bill for fair drug prices as several parties immediately decided to table it. The Belgian law would become the first to introduce the use of a pricing model such as the one being developed by ASCERTAIN as a future tool for pricing negotiations.<\/p>\n\n\n\n

The bill stipulates that the model should be based on transparent and objective criteria, precisely as AIM\u2019s calculator that takes into account several cost and value parameters, including research and production costs, reasonable margins, and additional benefits based on the innovative nature of the drug.<\/p>\n\n\n\n

MEPs expressed their strong interest for a broadly validated version of such a model as being developed in ASCERTAIN.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

For more information about Solidaris’s petition for fair drug prices, which garnered over 50,000 signatures, visit: Solidaris closes its petition for fair drug prices with more than 50,000 signatures<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris\u2019s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.<\/p>\n","protected":false},"author":5,"featured_media":1450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[13,12,14,11],"class_list":["post-1787","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein","tag-belgian-parliament","tag-drug-prices","tag-healthcare","tag-politics"],"yoast_head":"\nPresentation of AIM's Fair Price Model to the Belgian Parliament - ASCERTAIN<\/title>\n<meta name=\"description\" content=\"Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris\u2019s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Presentation of AIM's Fair Price Model to the Belgian Parliament\" \/>\n<meta property=\"og:description\" content=\"Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris\u2019s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-25T08:04:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-05T08:52:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2005\" \/>\n\t<meta property=\"og:image:height\" content=\"1254\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lena Jessen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Napisao\/la\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lena Jessen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/\"},\"author\":{\"name\":\"Lena Jessen\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\"},\"headline\":\"Presentation of AIM’s Fair Price Model to the Belgian Parliament\",\"datePublished\":\"2024-04-25T08:04:27+00:00\",\"dateModified\":\"2024-06-05T08:52:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/\"},\"wordCount\":193,\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"keywords\":[\"belgian parliament\",\"drug prices\",\"healthcare\",\"politics\"],\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"hr\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/\",\"name\":\"Presentation of AIM's Fair Price Model to the Belgian Parliament - ASCERTAIN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"datePublished\":\"2024-04-25T08:04:27+00:00\",\"dateModified\":\"2024-06-05T08:52:13+00:00\",\"description\":\"Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris\u2019s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/iStock-825537944_Liderina-scaled-e1680608197278.jpg\",\"width\":2005,\"height\":1254},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/hr\\\/pocetna-stranica\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Presentation of AIM’s Fair Price Model to the Belgian Parliament\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/person\\\/84cb4791d2eba62e68ecb7f29dba9391\",\"name\":\"Lena Jessen\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Presentation of AIM's Fair Price Model to the Belgian Parliament - ASCERTAIN","description":"Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris\u2019s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/","og_locale":"hr_HR","og_type":"article","og_title":"Presentation of AIM's Fair Price Model to the Belgian Parliament","og_description":"Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris\u2019s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.","og_url":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/","og_site_name":"ASCERTAIN","article_published_time":"2024-04-25T08:04:27+00:00","article_modified_time":"2024-06-05T08:52:13+00:00","og_image":[{"width":2005,"height":1254,"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","type":"image\/jpeg"}],"author":"Lena Jessen","twitter_card":"summary_large_image","twitter_creator":"@ASCERTAIN_EU","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Napisao\/la":"Lena Jessen","Procijenjeno vrijeme \u010ditanja":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/#article","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/"},"author":{"name":"Lena Jessen","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391"},"headline":"Presentation of AIM’s Fair Price Model to the Belgian Parliament","datePublished":"2024-04-25T08:04:27+00:00","dateModified":"2024-06-05T08:52:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/"},"wordCount":193,"publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"image":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","keywords":["belgian parliament","drug prices","healthcare","politics"],"articleSection":["Allgemein"],"inLanguage":"hr"},{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/","url":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/","name":"Presentation of AIM's Fair Price Model to the Belgian Parliament - ASCERTAIN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","datePublished":"2024-04-25T08:04:27+00:00","dateModified":"2024-06-05T08:52:13+00:00","description":"Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris\u2019s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/"]}]},{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/iStock-825537944_Liderina-scaled-e1680608197278.jpg","width":2005,"height":1254},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/presentation-of-aims-fair-price-model-to-the-belgian-parliament\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/hr\/pocetna-stranica\/"},{"@type":"ListItem","position":2,"name":"Presentation of AIM’s Fair Price Model to the Belgian Parliament"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]},{"@type":"Person","@id":"https:\/\/www.access2meds.eu\/#\/schema\/person\/84cb4791d2eba62e68ecb7f29dba9391","name":"Lena Jessen"}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/1787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/comments?post=1787"}],"version-history":[{"count":2,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/1787\/revisions"}],"predecessor-version":[{"id":1842,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/posts\/1787\/revisions\/1842"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media\/1450"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/media?parent=1787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/categories?post=1787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.access2meds.eu\/hr\/wp-json\/wp\/v2\/tags?post=1787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}